SPC263
Doravirín eða lyfjafræðilega viðunandi salt þar af
Status:
VeittApplication date:
5.4.2019Application published:
15.5.2019Grant published:
15.4.2021
Max expiry date:
26.11.2033Medicine name:
PIFELTROMedicine for children:
No
Timeline
Today
5.4.2019Application
15.5.2019Publication
15.4.2021Registration
26.11.2033Expires
Marketing license
IS authorization number:
EU/1/18/1332/001-002Date:
5.12.2018
Foreign authorization number:
EU/1/18/1332Date:
22.11.2018
Owner
Name:
Merck Canada Inc.Address:
16711 Trans-Canada Highway, Kirkland, QC H9H 3L1 CA
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2552902